Why the study?
Polygenic risk scores can potentially improve coronary artery disease prediction beyond traditional models, but their utility and predictive performance needed evaluation in the Latvian population.
Does a polygenic risk score improve the prediction of early-onset coronary artery disease when added to conventional risk factors in a Latvian population?
Population
90 early-onset CAD patients and 43 angiographic controls in Latvia
Comparison
PRS and pathway-specific PRS vs conventional risk factors
Design
Case-control study
Key result
Polygenic risk scores were significantly higher in early-onset CAD patients than controls (mean 0.31 vs -0.65; p<0.0001), and combining PRS with clinical factors yielded an AUC of 0.933.
Authors
Loading...
PRS may refine early CAD prediction in similar populations; leaves open prospective validation before clinical adoption.
Case-Control (n=133)
Does a polygenic risk score improve the prediction of early-onset coronary artery disease when added to conventional risk factors in a Latvian population?
Absolute Event Rate: 0.31% vs -0.65%
p-value: p=<0.0001
Integrating a polygenic risk score with traditional clinical risk factors significantly enhances the predictive accuracy for early-onset coronary artery disease.
Kanašniece et al. (2026) conducted a case-control in Early-onset coronary artery disease (CAD) (n=133). Polygenic risk score (PRS) vs. Controls without atherosclerotic lesions was evaluated on Polygenic risk score difference and predictive accuracy for early-onset CAD (p=<0.0001). Polygenic risk scores were significantly higher in early-onset CAD patients than controls (mean 0.31 vs -0.65; p<0.0001), and combining PRS with clinical factors yielded an AUC of 0.933.